Home
Science News
Academia
Campus Konnect
Researcher Spotlight
Faculty Konnect
Industry
Pharma & Biopharma
Vaccine and Technology
Industry Experts
Regulatory
Startup
Funding & Grants
Incubation Center
Startup Konnect
Career
Career opportunities
Award, fellowship & grant
Events
Career Konnect
Mentor Konnect
Storify India
Search
BioPatrika
BioPatrika
Go
Search
Home
Science News
Academia
Campus Konnect
Researcher Spotlight
Faculty Konnect
Industry
Pharma & Biopharma
Vaccine and Technology
Industry Experts
Regulatory
Startup
Funding & Grants
Incubation Center
Startup Konnect
Career
Career opportunities
Award, fellowship & grant
Events
Career Konnect
Mentor Konnect
Storify India
Tag Results:
Biopharma
Academia
Award, fellowship & grant
Business and Market Strategy
Campus Konnect
Career
Career Konnect
Pharma & Biopharma
Lupin Expands Diabetes Portfolio with Huminsulin Acquisition
Pharma & Biopharma
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
Pharma & Biopharma
U.S. FDA Approves Biocon Biologics’ YESINTEK™, Bmab 1200 biosimilar
Regulatory
EMA Grants GMP Certificate to CuraTeQ Biologics
Researcher Spotlight
Enhance Proteomics: FAPP for Enhanced Bottom-Up Proteomics
Vaccine and Technology
Automated Pump: FDA Approves Next-Gen Insulin System
Startup Konnect
Fibroheal launches post operative wound care and wound closure dressings range for infected and non infected wounds using silk
Researcher Spotlight
Raman spectroscopy an emerging analytical technique in biopharmaceuticals
Researcher Spotlight
Impact of mAb Aggregation on its Biological Activity
Load more
m⁶A RNA Methylation Shapes Black Pepper Immunity
June 15, 2026
Rice Histone H2A.X Identified as a Master Regulator of Development and Yield
June 12, 2026
Scispot Raises $8 Million Series A to Accelerate AI-Powered Life Sciences Labs
June 10, 2026
Vyome Advances VT-1953 and Expands Immunology Pipeline Through TATA-Backed Licensing Deal
June 9, 2026
Johnson & Johnson Acquires Firefly Bio for $1 Billion to Advance KRAS Cancer Therapies
June 9, 2026